Effect of ulinastatin on perioperative inflammatory response to coronary artery bypass grafting with cardiopulmonary bypass

Journal of Central South University (Medical Sciences)

Volumn 35, Issue 2, 2010, Pages 107-110

  Zhou, Qi ^a   Wang, Gang ^a   Gao, Changqing ^a   Chen, Tingling ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cardiopulmonary bypass; Coronary artery bypass grafting; Inflammatory response; Ulinastatin

Indexed keywords

GLYCOPROTEIN; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN;

AGED; ARTICLE; BLOOD; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL;

AGED; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; FEMALE; GLYCOPROTEINS; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949857334     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2010.02.003     Document Type: Article

References (13)

1. Kirklin J K, Westaby S , Blackstone E H, et al. Complement and the damaging effects of cardiopulmonary bypass [J]. J Thorac Cardiovasc Surg, 1983, 86(6): 845-857.
2. Kapoor M C, Ramachandran T R. Inflammatory response to cardiac surgery and strategies to overcome it [ J ]. Ann Card Anaesth, 2004, 7(2): 113-128.
3. Samankatiwat P, Samartzis I, Lertsithichai P, et al. Leucocyte depletion in cardiopulmonary bypass: a comparison of four strategies[J]. Perfusion, 2003, 18(2): 95-105.
4. Hirai S, Sueda T, Orihashi K, et al. Kinetics of pro-inflammatory cytokines release in cardiac surgery with cardiopulmonary bypass[J]. J Thorac Cardiovasc Surg, 2001, 49(4): 216-219.
5. Rothenburger M, Trosch F, Markewitz A, et al. Leukocyte activation and phagocytotic activity in cardiac surgery and infection [J]. Cardiovasc Surg, 2002, 10(5): 470-475.
6. Mojcik C F, Levy J H. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass [J]. Ann Thorac Surg, 2001, 71(2): 745-754.
7. Hayashida N, Chinara S, Tayama E, et al. Antiinflammatory effects of colforsin daropate hydrochloride, a novel water-soluble forskolin derivative [J]. Ann Thorac Surg, 2001 , 71 ( 6 ): 1931-1938.
8. Richter J A, Meisner H, Tassani P, et al. Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting [J]. Ann Thorac Surg, 1999, 69(1): 77-83.
9. Sato Y, Ishikaw S, Otaki A, et al. Induction of acute - phase reactive substances during open-heart surgery and efficacy of ulinastatin, inhibiting cytokines and postoperative organ injury [J]. Jpn J Thorac Cardiovasc Surg, 2000, 48(7): 428-434.
10. JING Liyan, XU Junmei, HE Zhibiao, et al. Effect of ulinastain on the expression of hemeaxygenase-1 in oleic acid-induced acute lung injurg in rats [J]. J Cent South Univ. Med Sci, 2007, 32(4): 675-678.
11. Nakamura H , Abe S , Shibata Y , et al. Inhibition of neutrophil elastase-induced interleukin-8 gene expression by urinary trypsin inhibitor in human bronchial epithelial cells [J]. Int Arch Allergy Immunol, 1997, 112(2): 157-162.
12. Hiyama A , Takeda J , Rotate Y, et al. Ahuman urinary protease inhibitor ( ulinastatin ) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass [J]. J Cardiothorac Vase Anesth, 1997, 11(5): 580-584.
13. Bingyang J , Jinping L, Mingzheng L, et al. Effects of urinary protease inhibitor on inflammatory response during on-pump coronary revascularization. Effect of ulinastation on inflammatory response[J]. J Cardiovasc Surg, 2007, 48(4): 497-503.